Ethyol 500 mg/10mL

Ethyol Injection, powder, lyophilized, for solution is a product of Cumberland Pharmaceuticals

Group: Approved Detoxifying Agents for Antineoplastic Treatment

Name: Ethyol

Dosage: Injection, powder, lyophilized, for solution

Strength: 500 mg/10mL

Route: Intravenous

Pharmaceutical company : Cumberland Pharmaceuticals

You can also find other alternative products such as : Ethyol (500 mg/10mL) from Med Immune, Llc Amifostine (500 mg/10mL) from Bedford Pharmaceuticals Ethyol (500 mg/10mL) from Cumberland Pharmaceuticals Amifostine (500 mg/10mL) from Bedford Pharmaceuticals

Indication: For reduction in the cumulative renal toxicity in patients with ovarian cancer (using cisplatin) and moderate to severe xerostomia in patients undergoing post-operative radiation treatment for head and neck cancer.

Category:

  • Cytoprotective Agent
  • Detoxifying Agents for Antineoplastic Treatment
  • Free Radical Scavenging Activity
  • Hypotensive Agents
  • Organophosphates
  • Organophosphorus Compounds
  • Organothiophosphates
  • Organothiophosphorus Compounds
  • Protective Agents
  • Radiation-Protective Agents
  • Sulfur Compounds
  • Food Interactions; Not Available

    Amifostine Definition:
    A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.

    More Ethyol 500 mg/10mL

    ETHYOL Rx

    Therapeutic indications Cytoprotective and supportive care agents


    Keep patient in supine position..Indications for ETHYOL: To reduce cumulative renal toxicity associated with repeated administration of cisplatin in patients with advanced ovarian cancer.. Hypocalcemia risk (eg, nephrotic syndrome, multiple doses of Ethyol); monitor serum calcium..


    ETHYOL Rx

    Therapeutic indications Cytoprotective and supportive care agents


    Keep patient in supine position.. Pregnancy.. Interactions: Caution with drugs that can cause hypotension..


    Ethyol Vial

    Therapeutic indications Amifostine is used to decrease the risk of kidney problems caused by treatment with a certain anti-cancer drug (cisplatin)

    However, get medical help right away if you notice any symptoms of a serious allergic reaction, including: fever, swollen lymph nodes, rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.. You may report side effects to Health Canada at 1-866-234-2345..In the US -Call your doctor for medical advice about side effects..
    During pregnancy, this medication should be used only when clearly needed.. Therefore, before using this product, tell your doctor or pharmacist of all the products you use.. Do not start, stop, or change the dosage of any medicine before checking with your doctor or pharmacist first..


    Other drugs that have exactly the same effects, dosage, intended use, side effects, route of administration, risks, safety, and strength as Amifostine

    Name Pharmaceutical
    Amifostine 50 mg/1mLSun Pharma Global FZE
    Amifostine 50 mg/1mLSun Pharmaceutical Industries Limited

    Effects of Ethyol 500 mg/10mL by reaction with another drug or drugs

  • Metyrosine may increase the hypotensive activities of Amifostine.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Aldesleukin.
  • Phenobarbital may increase the hypotensive activities of Amifostine.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Tolcapone.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Verapamil.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Streptokinase.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Papaverine.
  • Urapidil may increase the hypotensive activities of Amifostine.
  • Selexipag may increase the hypotensive activities of Amifostine.
  • Platelet Activating Factor may increase the hypotensive activities of Amifostine.
  • Terlipressin may increase the hypotensive activities of Amifostine.
  • Metyrosine may increase the hypotensive activities of Amifostine.
  • Carteolol may increase the hypotensive activities of Amifostine.
  • Minoxidil may increase the hypotensive activities of Amifostine.
  • Nebivolol may increase the hypotensive activities of Amifostine.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Empagliflozin.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Furosemide.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Terazosin.
  • The risk or severity of adverse effects can be increased when Amifostine is combined with Imipramine.
  • Rescinnamine may increase the hypotensive activities of Amifostine.